Status:
UNKNOWN
Cycloplegic Refraction in Pediatric Patients With Esotropia
Lead Sponsor:
Islamic Hospital, Jordan
Collaborating Sponsors:
Jordan University of Science and Technology
Yarmouk University
Conditions:
Cycloplegia
Refractive Errors
Eligibility:
All Genders
3-16 years
Phase:
PHASE4
Brief Summary
The primary outcome of this study is to compare cyclopentolate 1% and tropicamide 1% for cycloplegic refractions in pediatric populations with esotropia. This will be a prospective double-blinded rand...
Detailed Description
Many studies have been conducted over the last few decades to assess the need for cycloplegia in assessing refractive errors. Plenty of research on pediatric populations has demonstrated that a lack o...
Eligibility Criteria
Inclusion
- Alignment: subjects with esotropia Age: 3-16 years Brown irides; grade 4 and 5 using iris color classification system developed by Seddon et al Duration: 2 different visits ≥ 1 week apart within 3 months
Exclusion
- Abnormal red reflex (e.g., media opacity) History of heart or neurological diseases History of developmental delay History of a previous allergy to cycloplegic agents Presence of syndromes (e.g., Down's syndrome) History of intraocular surgery
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06077682
Start Date
September 1 2023
End Date
December 1 2024
Last Update
October 11 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Yarmouk University
Irbid, Jordan
2
Hamad Medical Corporation
Doha, Qatar, 3050